Peripheral Neuropathy Trial, Recruiting NCT07661290 Sponsor: Cairo University Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07661290
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 40 and 60 years of age
  • People with a Body Mass Index (BMI) between 18.5 and 35, which covers the normal to overweight range
  • People who have been diagnosed with cervical radiculopathy (a nerve-related condition in the neck) confirmed by a physical examination and imaging such as an MRI
  • People with a pain level of at least 4 out of 10 on a standard pain scale
  • People who have never had surgery on their neck or cervical spine
  • People who are able to give their agreement to take part and follow the study requirements

Who may not be able to join:

  • People who are pregnant or planning to become pregnant
  • People with serious health conditions that could affect the study results, such as uncontrolled diabetes, cancer, or inflammatory diseases affecting the whole body
  • People with severe narrowing of the spinal canal in the neck or pressure on the spinal cord
  • People with any form of cancer, an active infection, or skin problems on the neck
  • People currently using strong pain medications such as opioids, which could affect the study results
  • People who have received high-power laser therapy on the relevant area within the last six months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hussein Ahmed Shaker, Professor, Cairo university

Phone: +201119221077

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
10 July 2026
Est. completion
20 November 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Disc height; Disc hydration; Disc protrusion

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov